ZEN Graphene Solutions Ltd (ZEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.103x

Based on the latest financial reports, ZEN Graphene Solutions Ltd (ZEN) has a cash flow conversion efficiency ratio of -0.103x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.21 Million ≈ $-874.48K USD) by net assets (CA$11.69 Million ≈ $8.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ZEN Graphene Solutions Ltd net asset quality index to measure how much of total assets are equity-financed.

ZEN Graphene Solutions Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how ZEN Graphene Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow reinvestment rate of ZEN Graphene Solutions Ltd to assess the company's total reinvestment commitment from operating cash flow.

ZEN Graphene Solutions Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ZEN Graphene Solutions Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
PYRAMID TECHNOPLAST ORD (BSE)
NSE:PYRAMID
-0.025x
Hyundai C&F Inc
KO:227840
0.042x
Seco/Warwick SA
WAR:SWG
-0.098x
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
0.026x
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SHE:002731
0.045x
5E Advanced Materials Inc
AU:5EA
-0.057x
Frontier Lithium Inc
V:FL
0.266x
biote Corp
NASDAQ:BTMD
-0.081x

Annual Cash Flow Conversion Efficiency for ZEN Graphene Solutions Ltd (2010–2025)

The table below shows the annual cash flow conversion efficiency of ZEN Graphene Solutions Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see how much is ZEN Graphene Solutions Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 CA$14.75 Million
≈ $10.67 Million
CA$-6.28 Million
≈ $-4.54 Million
-0.426x -6.72%
2024-03-31 CA$20.17 Million
≈ $14.59 Million
CA$-8.05 Million
≈ $-5.82 Million
-0.399x +6.40%
2023-03-31 CA$30.38 Million
≈ $21.98 Million
CA$-12.96 Million
≈ $-9.37 Million
-0.426x -84.42%
2022-03-31 CA$34.55 Million
≈ $24.99 Million
CA$-7.99 Million
≈ $-5.78 Million
-0.231x -253.83%
2021-03-31 CA$27.46 Million
≈ $19.87 Million
CA$-1.79 Million
≈ $-1.30 Million
-0.065x -23.88%
2020-03-31 CA$25.71 Million
≈ $18.60 Million
CA$-1.36 Million
≈ $-981.19K
-0.053x -10.97%
2019-03-31 CA$24.90 Million
≈ $18.01 Million
CA$-1.18 Million
≈ $-856.16K
-0.048x -4.95%
2018-03-31 CA$22.07 Million
≈ $15.97 Million
CA$-999.86K
≈ $-723.28K
-0.045x +39.83%
2017-03-31 CA$22.71 Million
≈ $16.43 Million
CA$-1.71 Million
≈ $-1.24 Million
-0.075x +3.96%
2016-03-31 CA$21.45 Million
≈ $15.52 Million
CA$-1.68 Million
≈ $-1.22 Million
-0.078x -28.41%
2015-03-31 CA$20.42 Million
≈ $14.77 Million
CA$-1.25 Million
≈ $-901.60K
-0.061x +46.21%
2014-03-31 CA$21.02 Million
≈ $15.21 Million
CA$-2.39 Million
≈ $-1.73 Million
-0.113x -13.81%
2013-03-31 CA$16.45 Million
≈ $11.90 Million
CA$-1.64 Million
≈ $-1.19 Million
-0.100x +22.61%
2012-03-31 CA$10.23 Million
≈ $7.40 Million
CA$-1.32 Million
≈ $-953.27K
-0.129x -32.33%
2011-03-31 CA$11.14 Million
≈ $8.06 Million
CA$-1.08 Million
≈ $-784.55K
-0.097x -684.51%
2010-03-31 CA$3.04 Million
≈ $2.20 Million
CA$-37.74K
≈ $-27.30K
-0.012x --

About ZEN Graphene Solutions Ltd

V:ZEN Canada Medical Instruments & Supplies
Market Cap
$73.57 Million
CA$101.70 Million CAD
Market Cap Rank
#20333 Global
#694 in Canada
Share Price
CA$0.95
Change (1 day)
+21.79%
52-Week Range
CA$0.54 - CA$1.50
All Time High
CA$7.18
About

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more